Literature DB >> 3097069

Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth.

R J Wallace, D R Nash, L C Steele, V Steingrube.   

Abstract

Based on previous success with rapidly growing mycobacteria, a microdilution MIC system was devised for slowly growing mycobacterial species using 7H9 broth. Test drugs included isoniazid, rifampin, ethambutol, streptomycin, clofazamine, and sulfamethoxazole. Sixty isolates of four mycobacterial species, including Mycobacterium tuberculosis, from patients who had never received drug therapy were evaluated in the system, as well as 25 drug-resistant isolates and 11 control strains. MICs were read when good macroscopic control growth was evident, a period which varied with each species. Most species exhibited a narrow range of MICs with easily discernible growth endpoints. The aminoglycosides, ethambutol, clofazamine, and sulfamethoxazole were the only drugs with activity against all species at clinically achievable levels in serum. Correlation between susceptibilities by the proportion method in agar with single drug concentrations and the broth method were excellent for M. tuberculosis, M. kansasii, and M. marinum for isoniazid, rifampin, and ethambutol. Isolates of the M. avium complex were much more susceptible in broth than in agar for rifampin, ethambutol, and streptomycin. Given the successful transition of most microbiology laboratories to MIC plates for other bacterial species, this method would allow for testing of multiple drugs at multiple concentrations and has good potential for evaluation of drug combinations and drug-resistant isolates.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3097069      PMCID: PMC269082          DOI: 10.1128/jcm.24.6.976-981.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Minimal inhibitory concentrations of 34 antimicrobial agents for control strains Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853.

Authors:  R J Fass; J Barnishan
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

2.  THE DETERMINATION OF SULFONAMIDE SUSCEPTIBILITY OF BACTERIA.

Authors:  A W BAUER; J C SHERRIS
Journal:  Chemotherapia (Basel)       Date:  1964

3.  Evaluation of rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis.

Authors:  S H Siddiqi; J P Libonati; G Middlebrook
Journal:  J Clin Microbiol       Date:  1981-05       Impact factor: 5.948

4.  In vitro activity of trimethoprim and sulfamethoxazole against the nontuberculous mycobacteria.

Authors:  R J Wallace; K Wiss; M B Bushby; D C Hollowell
Journal:  Rev Infect Dis       Date:  1982 Mar-Apr

5.  Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution.

Authors:  J M Swenson; C Thornsberry; V A Silcox
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

6.  Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens.

Authors:  G D Roberts; N L Goodman; L Heifets; H W Larsh; T H Lindner; J K McClatchy; M R McGinnis; S H Siddiqi; P Wright
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

7.  Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities.

Authors:  R J Wallace; J M Swenson; V A Silcox; M G Bullen
Journal:  J Infect Dis       Date:  1985-09       Impact factor: 5.226

8.  MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE.

Authors:  G CANETTI; S FROMAN; J GROSSET; P HAUDUROY; M LANGEROVA; H T MAHLER; G MEISSNER; D A MITCHISON; L SULA
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

9.  Evaluation of the BACTEC radiometric method for detection of 1% resistant populations of Mycobacterium tuberculosis.

Authors:  J J Tarrand; D H Gröschel
Journal:  J Clin Microbiol       Date:  1985-06       Impact factor: 5.948

10.  In vitro susceptibility of mycobacteria species other than Mycobacterium tuberculosis to amikacin, cephalosporins and cefoxitin.

Authors:  H Haas; J Michel; T G Sacks
Journal:  Chemotherapy       Date:  1982       Impact factor: 2.544

View more
  58 in total

1.  A novel mechanism of growth phase-dependent tolerance to isoniazid in mycobacteria.

Authors:  Makoto Niki; Mamiko Niki; Yoshitaka Tateishi; Yuriko Ozeki; Teruo Kirikae; Astrid Lewin; Yusuke Inoue; Makoto Matsumoto; John L Dahl; Hisashi Ogura; Kazuo Kobayashi; Sohkichi Matsumoto
Journal:  J Biol Chem       Date:  2012-05-30       Impact factor: 5.157

2.  Chemical modification of capuramycins to enhance antibacterial activity.

Authors:  Elena Bogatcheva; Tia Dubuisson; Marina Protopopova; Leo Einck; Carol A Nacy; Venkata M Reddy
Journal:  J Antimicrob Chemother       Date:  2010-12-23       Impact factor: 5.790

3.  "Mycobacterium ulcerans subsp. shinshuense" isolated from a skin ulcer lesion: identification based on 16S rRNA gene sequencing.

Authors:  Kazue Nakanaga; Norihisa Ishii; Koichi Suzuki; Kazunari Tanigawa; Masamichi Goto; Tsutomu Okabe; Hideaki Imada; Akemi Kodama; Tomotada Iwamoto; Hiroshi Takahashi; Hajime Saito
Journal:  J Clin Microbiol       Date:  2007-09-19       Impact factor: 5.948

4.  In vitro antimycobacterial activities of capuramycin analogues.

Authors:  Venkata M Reddy; Leo Einck; Carol A Nacy
Journal:  Antimicrob Agents Chemother       Date:  2007-12-10       Impact factor: 5.191

5.  Double recombinant Mycobacterium bovis BCG strain for screening of primary and rationale-based antimycobacterial compounds.

Authors:  Vandana Singh; Rajesh Kumar Biswas; Bhupendra N Singh
Journal:  Antimicrob Agents Chemother       Date:  2013-12-16       Impact factor: 5.191

6.  Nineteen cases of Buruli ulcer diagnosed in Japan from 1980 to 2010.

Authors:  Kazue Nakanaga; Yoshihiko Hoshino; Rie Roselyne Yotsu; Masahiko Makino; Norihisa Ishii
Journal:  J Clin Microbiol       Date:  2011-08-31       Impact factor: 5.948

7.  Tuberculosis and trimethoprim-sulfamethoxazole.

Authors:  Pierre Forgacs; Nancy L Wengenack; Leslie Hall; Sarah K Zimmerman; Mark L Silverman; Glenn D Roberts
Journal:  Antimicrob Agents Chemother       Date:  2009-06-29       Impact factor: 5.191

Review 8.  Susceptibility testing of Mycobacterium avium complex isolates.

Authors:  L Heifets
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

9.  Simple fibroblast-based assay for screening of new antimicrobial drugs against Mycobacterium tuberculosis.

Authors:  Takemasa Takii; Yoshifumi Yamamoto; Taku Chiba; Chiyoji Abe; John T Belisle; Patrick J Brennan; Kikuo Onozaki
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

10.  Synthesis and Antitubercular Activity of New Benzo[b]thiophenes.

Authors:  Pravin S Mahajan; Mukesh D Nikam; Laxman U Nawale; Vijay M Khedkar; Dhiman Sarkar; Charansingh H Gill
Journal:  ACS Med Chem Lett       Date:  2016-06-28       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.